(Q38985924)

8 September 2017

title

Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor (English)

1 reference

8 September 2017

0 references

Naoyuki Kawao

1

1 reference

8 September 2017

Yukinori Tamura

2

1 reference

8 September 2017

Katsumi Okumoto

3

1 reference

8 September 2017

Masato Yano

4

1 reference

8 September 2017

Kiyotaka Okada

5

1 reference

8 September 2017

Osamu Matsuo

6

1 reference

8 September 2017

Hiroshi Kaji

7

1 reference

8 September 2017

publication date

10 June 2014

1 reference

American Journal of Physiology - Endocrinology and Metabolism

8 September 2017

published in

1 reference

8 September 2017

volume

307

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

E278-88

1 reference

Plasminogen activators direct reorganization of the liver lobule after acute injury

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Fracture healing under healthy and inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Increased bone formation in mice lacking plasminogen activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Generation and characterization of urokinase receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

The role of annexin 2 in osteoblastic mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Primary culture and phenotyping of murine chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Role of plasminogen in macrophage accumulation during liver repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

1[alpha],25-dihydroxyvitamin D(3) enhances annexin II dependent proliferation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Fracture healing in mice deficient in plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Role of osteoglycin in the linkage between muscle and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Plasminogen activator system in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00129.2014

10.1152/AJPENDO.00129.2014

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference